Rituximab as salvage therapy for refractory chronic GVHD (Q80709875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Rituximab as salvage therapy for refractory chronic GVHD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

M Mohty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

N Marchetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

J El-Cheikh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

C Faucher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

S Fürst

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

D Blaise

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

18 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

909-911

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18278073%20AND%20SRC:MED&resulttype=core&format=json

Chronic graft-versus-host disease

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

Rituximab for steroid-refractory chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

Rituximab responsive refractory acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

Rituximab is effective for extensive steroid-refractory chronic graft-vs.-host-disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021

The management and outcome of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.12

7 January 2021